ET Wealth Reader's Query: My wife and I have had a floater health insurance policy for over four years. We declared diabetes as a pre-exist...

Japan's Prime Minister Sanae Takaichi's visit to India signals a deepening economic partnership, focusing on resilient supply chains and hi...

Japan is aiming for over 1% real economic growth annually, a significant jump from its recent average. This ambitious plan, detailed in a d...

Northeastern Japan felt the tremors of a magnitude-6.1 earthquake early Sunday, the latest in a string of significant seismic activity. Whi...

Nithin Kamath questions India's slow adoption of affordable GLP-1 weight-loss drugs, despite rising obesity. He points to challenges like l...

Japan faces severe transport chaos and landslide threats as two tropical storms, Mekkhala and Higos, converge with a seasonal rain front. O...

Manipur Chief Minister Yumnam Khemchand Singh revealed that drug trafficking routes have shifted significantly post-2023 crisis, largely di...

Initial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...

Union Home Minister Amit Shah announced plans to amend the NDPS Act to combat drug syndicates, emphasizing a strict approach against peddle...

Two tropical storms are threatening Japan, forcing over 100 flight cancellations and prompting evacuations due to flood and landslide risks...

India's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...

Veteran Indian sprinter Srabani Nanda, at 35, credits her enduring success and recent Asian Relays gold to unwavering hunger and a commitme...

Young Indian professionals, particularly in IT and finance, are facing a heart disease crisis due to unhealthy lifestyles. Leading cardiac ...

India's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...

Fixed dose combination banned full list: India has banned 16 fixed-dose combination drugs, including certain antibiotics and antispasmodics...

In a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...

Indian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...